Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Rabies Vaccine (Human Diploid Cell) Trial With Different Immunization Schedules in 10–60-Year-Olds
CTR20254794Phase 3Active
- Sponsor
- Ab&B Bio-tech Co., Ltd.
- Start
- Feb 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Human Diploid Cell Rabies Vaccine in rabies, sponsored by Ab&B Bio-tech Co., Ltd.. Started Feb 2026; status: active.
02
Drugs
Human Diploid Cell Rabies Vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20254794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254794.